Dr. Kyle Schachtschneider is a Research Assistant Professor in the Department of Radiology at the University of Illinois at Chicago College of Medicine. He is a junior member focusing on clincal and translational cancer research.
Dr. Schachtschneider has background in bioinformatics, epigenomics, and use of pigs in translational biomedical research, and focused his research efforts over the past 3 years on development and utilization of porcine caner models. As a PhD candidate at the University of Illinois, he successfully demonstrated the utility of fecal transplantation as a therapeutic tool to affect systemic immune responses in a porcine biomedical model. His work on porcine biomedical models continued as a Postdoctoral Research Associate at Wageningen University in the Netherlands.
Following his time overseas he took a position in the clinically focused Department of Radiology at the University of Illinois at Chicago in order to develop the clinical collaborations and knowledge required to focus my research efforts towards translation into clinical practice. During his time at UIC, he has overseen a number of research projects in the clinical and translational science space.
Dr. Schachtschneider designed and conducted experiments to develop and characterize the translational Oncopig hepatocellular carcinoma (HCC) model to improve HCC detection and treatment strategies.
He is leading a collaborative effort with the Johns Hopkins Drug Discovery Group evaluating prodrug pharmacokinetics utilizing the OCM as a first step towards human clinical trials. Together his knowledge and research experiences highlight his interests in clinical and translational cancer research.